/
/
/

Eris Lifesciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)1,301.00
Volume (₹)69,094.00
High (₹)1,332.20
Upper Circuit1,564.20
Low (₹)1,301.00
Lower Circuit1,042.80
Prev Close1,303.50
52W High (₹)1,797.60
Price1,319.00
52W Low (₹)1,200.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)18069.20 Cr
Div. Yield (%)0.00
PE Ratio28.06
Debt to Equity0.59
Price to Book4.62
Book Value280.75
EPS (TTM)46.46
Face Value1.00
ROE (%)19.23

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ERISNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
1319+4.2 (0.32%)
1265.10
1349.90
18,069Cr

Key Highlights of Eris Lifesciences Ltd Balance Sheet

Eris Lifesciences Ltd balance sheet discloses shareholders' funds of ₹13.62Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹13.62Cr, and the reserves and surplus of the company is ₹2491.12Cr.

The company has its non-current liabilities with total liabilities of ₹4956.08Cr as of 2025-03-31.

The current liabilities are ₹1010.95Cr as of 2025-03-31. At the same time, current assets are ₹644.55Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹991.27Cr and tangible assets of ₹2412.18Cr, provided in the Eris Lifesciences Ltd financial statements.